JSW
GILD icon

Journey Strategic Wealth’s Gilead Sciences GILD Stock Holding History

Journey Strategic Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.64M Buy
11,794
+1,616
+16% +$226K 0.04% 125
2025
Q4 		$1.25M Buy
10,178
+74
+0.7% +$8.99K 0.03% 145
2025
Q3 		$1.12M Sell
10,104
-297
-3% -$33.8K 0.03% 156
2025
Q2 		$1.15M Buy
10,401
+4,053
+64% +$431K 0.04% 144
2025
Q1 		$711K Buy
6,348
+435
+7% +$44.9K 0.02% 179
2024
Q4 		$546K Buy
5,913
+288
+5% +$25.9K 0.02% 203
2024
Q3 		$472K Buy
5,625
+995
+21% +$75.9K 0.02% 227
2024
Q2 		$318K Buy
4,630
+1,741
+60% +$116K 0.01% 235
2024
Q1 		$212K Buy
2,889
+400
+16% +$30.8K 0.01% 276
2023
Q4 		$202K Buy
+2,489
New +$194K 0.01% 205
2023
Q2 		– Sell
-3,785
Closed -$314K – 231
2023
Q1 		$314K Buy
3,785
+370
+11% +$30.6K 0.03% 151
2022
Q4 		$293K Buy
+3,415
New +$270K 0.03% 144
2022
Q1 		– Sell
-3,572
Closed -$259K – 199
2021
Q4 		$259K Buy
+3,572
New +$246K 0.03% 142

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Journey Strategic Wealth's GILD Position: Q1 2026 in Review

Journey Strategic Wealth increased its Gilead Sciences (GILD) stake by 16% in Q1 2026, buying an estimated $226K and bringing the position to 11,794 shares worth $1.64M. The position accounts for 0.04% of the portfolio, ranked #125.

Journey Strategic Wealth first reported a position in GILD in Q4 2021 and has held it in 13 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Journey Strategic Wealth held 11,794 shares of Gilead Sciences worth $1.64M as of Q1 2026.
  • Journey Strategic Wealth bought 1,616 Gilead Sciences shares in Q1 2026, an estimated $226K.
  • Gilead Sciences made up 0.04% of Journey Strategic Wealth's portfolio in Q1 2026, its #125 holding.
  • Journey Strategic Wealth first reported a position in Gilead Sciences in Q4 2021 and has held it in 13 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.